What is the best pharmacologic treatment for sickle cell disease pain crises? (abre una nueva ventana)

Baker M, Hafner JW.

Fuente‎: Ann Emerg Med 2012;59(6):515-6.

Indexado en‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (abre una nueva ventana)

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (abre una nueva ventana)

Frei-Jones MJ, Field JJ, DeBaun MR.

Fuente‎: Pediatr Blood Cancer 2009;53(3):401-5.

Indexado en‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

https://www.ncbi.nlm.nih.gov/pubmed/19422031 (abre una nueva ventana)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (abre una nueva ventana)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Fuente‎: Thromb Haemost 2007;98(2):392-6.

Indexado en‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (abre una nueva ventana)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (abre una nueva ventana)

Okomo U, Meremikwu MM.

Fuente‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indexado en‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (abre una nueva ventana)

Guidelines for the management of the acute painful crisis in sickle cell disease. (abre una nueva ventana)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Fuente‎: Br J Haematol 2003;120(5):744-52.

Indexado en‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (abre una nueva ventana)

The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (abre una nueva ventana)

Ahmad FA, Macias CG, Allen JY.

Fuente‎: J Pediatr Hematol Oncol 2011;33(6):415-20.

Indexado en‎: PubMed 21792036

DOI‎: 10.1097/MPH.0b013e31821ed4ce

https://www.ncbi.nlm.nih.gov/pubmed/21792036 (abre una nueva ventana)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (abre una nueva ventana)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Fuente‎: Hemoglobin 2004;28(2):85-102.

Indexado en‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (abre una nueva ventana)

Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (abre una nueva ventana)

Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR.

Fuente‎: Blood 1998;92(9):3082-9.

Indexado en‎: PubMed 9787142

https://www.ncbi.nlm.nih.gov/pubmed/9787142 (abre una nueva ventana)

A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (abre una nueva ventana)

Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST.

Fuente‎: J Pediatr Hematol Oncol 2010;32(3):e91-4.

Indexado en‎: PubMed 20216237

DOI‎: 10.1097/MPH.0b013e3181c29c52

https://www.ncbi.nlm.nih.gov/pubmed/20216237 (abre una nueva ventana)

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (abre una nueva ventana)

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Fuente‎: Haematologica 2013;98(9):1375-82.

Indexado en‎: PubMed 23645695

DOI‎: 10.3324/haematol.2013.086637

https://www.ncbi.nlm.nih.gov/pubmed/23645695 (abre una nueva ventana)

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (abre una nueva ventana)

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

Fuente‎: JAMA 2003;289(9):1136-42.

Indexado en‎: PubMed 12622584

https://www.ncbi.nlm.nih.gov/pubmed/12622584 (abre una nueva ventana)

Predictors of bacteremia in febrile children with sickle cell disease. (abre una nueva ventana)

West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N.

Fuente‎: J Pediatr Hematol Oncol 2002;24(4):279-83.

Indexado en‎: PubMed 11972096

https://www.ncbi.nlm.nih.gov/pubmed/11972096 (abre una nueva ventana)